Page 126 - pharma 1 theoretical updated MNU_Neat
P. 126

Clinical pharmacy 2024/2025                            Level 3 Pharm D                             Pharmacology 1 (PO 502)

                               6- Cytoprotective agents (ex: Trimetazidine)

             This cyto-protection is obtained by providing enough energy to maintain an efficient

               myocardial contraction during ischemia
             It produces a metabolic switch via inhibition of fatty acid oxidation toward
               activation of glucose oxidation during ischemia

             It limits intracellular acidosis and sodium and calcium accumulation
             It preserves contractile function and limit cytolysis.
             It limits membrane damage induced by oxygen free radical.












                                7- Funny channel blocker (ex: Ivabradine)


             It inhibits funny channel (inhibit influx of both Na & K ion) in the SA node leading
               to hyperpolarization and inhibition of Ca contraction results in decreasing
               intracellular sodium and calcium overload improving oxygen supply and demand.

                                                                                       +
             It produces marked bradycardia so considered after βBs, Na  & CCBs





















                                                                                                     | P a g e    -  110 -
   121   122   123   124   125   126   127   128   129   130   131